Loss Per Share

6 Months Ended

Jun. 30, 2020

The following table is a reconciliation of the weighted average shares used in the computation of income (loss) per share for the periods presented (in thousands, except per share data):


	Three Months Ended June 30,						Six Months Ended June 30,
	2020		2019		2020		2019
Net loss	$	(23,268)	$	(22,485)	$	(35,266)	$	(51,612)
Net income attributable to non-controlling interests	8		57		48		88
Net loss attributable to JAKKS Pacific, Inc.	(23,276)		(22,542)		(35,314)		(51,700)
Preferred stock dividend	312		—		619		—
Net loss attributable to common stockholders	$	(23,588)	$	(22,542)	$	(35,933)	$	(51,700)
Weighted average common shares outstanding - basic and diluted	3,064		2,360		3,043		2,358
Loss per share available to common stockholders - basic and diluted	$	(7.70)	$	(9.55)	$	(11.81)	$	(21.93)

Basic earnings per share is calculated using the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated using the weighted average number of common shares and common share equivalents outstanding during the period (which consist of warrants, options, restricted stock awards, restricted stock units and convertible debt to the extent they are dilutive). The weighted average number of common shares outstanding for the three and six months ended June 30, 2019 excludes 311,284 shares repurchased pursuant to a prepaid forward share repurchase agreement associated with the issuance of the convertible senior notes due 2020. These shares were retired on September 13, 2019. Common share equivalents that could potentially dilute basic earnings per share in the future, which were excluded from the computation of diluted earnings per share due to being anti-dilutive, totaled 4,355,969 and 4,320,833 for the three and six months ended June 30, 2020, respectively. Common share equivalents that could potentially dilute basic earnings per share in the future, which were excluded from the computation of diluted earnings per share due to being anti-dilutive, totaled 2,767,554 for the three and six months ended June 30, 2019.